TITLE

Using Expression Profiling to Understand the Effects of Chronic Cadmium Exposure on MCF-7 Breast Cancer Cells

AUTHOR(S)
Lubovac-Pilav, Zelmina; Borràs, Daniel M.; Ponce, Esmeralda; Louie, Maggie C.
PUB. DATE
December 2013
SOURCE
PLoS ONE;Dec2013, Vol. 8 Issue 12, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Cadmium is a metalloestrogen known to activate the estrogen receptor and promote breast cancer cell growth. Previous studies have implicated cadmium in the development of more malignant tumors; however the molecular mechanisms behind this cadmium-induced malignancy remain elusive. Using clonal cell lines derived from exposing breast cancer cells to cadmium for over 6 months (MCF-7-Cd4, -Cd6, -Cd7, -Cd8 and -Cd12), this study aims to identify gene expression signatures associated with chronic cadmium exposure. Our results demonstrate that prolonged cadmium exposure does not merely result in the deregulation of genes but actually leads to a distinctive expression profile. The genes deregulated in cadmium-exposed cells are involved in multiple biological processes (i.e. cell growth, apoptosis, etc.) and molecular functions (i.e. cadmium/metal ion binding, transcription factor activity, etc.). Hierarchical clustering demonstrates that the five clonal cadmium cell lines share a common gene expression signature of breast cancer associated genes, clearly differentiating control cells from cadmium exposed cells. The results presented in this study offer insights into the cellular and molecular impacts of cadmium on breast cancer and emphasize the importance of studying chronic cadmium exposure as one possible mechanism of promoting breast cancer progression.
ACCESSION #
93398180

 

Related Articles

  • Clinical significance of CD151 overexpression in subtypes of invasive breast cancer. Kwon, M J; Park, S; Choi, J Y; Oh, E; Kim, Y J; Park, Y-H; Cho, E Y; Nam, S J; Im, Y-H; Shin, Y K; Choi, Y-L // British Journal of Cancer;2/28/2012, Vol. 106 Issue 5, p923 

    Background:CD151 is a member of the tetraspanin family, which interacts with laminin-binding integrins and other tetraspanins. This protein is implicated in motility, invasion, and metastasis of cancer cells, but the prevalence of CD151 expression in subtypes of breast cancers and its influence...

  • Estrogenic regulation of S6K1 expression creates a positive regulatory loop in control of breast cancer cell proliferation. Maruani, D M; Spiegel, T N; Harris, E N; Shachter, A S; Unger, H A; Herrero-González, S; Holz, M K // Oncogene;12/6/2012, Vol. 31 Issue 49, p5073 

    The 40S ribosomal S6 kinase 1 (S6K1) is an important regulator of cell growth. Expression of S6K1 is often elevated in breast cancer cells. However, the transcriptional mechanism of S6K1 overexpression is not understood. In this report, we demonstrate that estrogen activates expression of S6K1...

  • Amplification of Growth Regulatory Genes in Intraductal Breast Cancer Is Associated with Higher Nuclear Grade but Not with the Progression to Invasiveness. Glöckner, Sabine; Lehmann, Ulrich; Wilke, Nadine; Kleeberger, Wolfram; L¨anger, Florian; Kreipe, Hans // Laboratory Investigation (00236837);Apr2001, Vol. 81 Issue 4, p565 

    Ductal carcinoma in situ (DCIS), as an identifiable progenitor lesion of invasive breast cancer, represents a morphologically, biologically, and prognostically heterogeneous disease. It is not clear which molecular mechanisms are involved in progression to infiltrative growth. In this study, 83...

  • Diagnosis: Time for a change. Novak, Kristine // Nature Reviews Cancer;Jul2004, Vol. 4 Issue 7, p500 

    Focuses on a study by Songdong Meng and colleagues concerning the acquisition of HER-2 gene amplification as breast cancer progresses. Additional changes that accompany cancer progression; Indicator of the status of the primary tumor; Analysis of circulating tumor cells of patients with...

  • Allelic Imbalances of the egfr Gene as Key Events in Breast Cancer Progression -- the Concept of Committed Progenitor Cells. Agelopoulos, K.; Buerger, H.; Brandt, B. // Current Cancer Drug Targets;Aug2008, Vol. 8 Issue 5, p431 

    The introduction of concepts proposing multiple cellular subgroups in the normal female breast leads to the hypothesis that distinct cellular phenotypes in the female breast give rise to different subtypes of breast carcinomas e.g. expressing ER, HER2 and EGFR differentially. Therefore, origin...

  • MicroRNA miR-30 family regulates non-attachment growth of breast cancer cells. Ouzounova, Maria; Tri Vuong; Ancey, Pierre-Benoit; Ferrand, Mylène; Durand, Geoffroy; Le-Calvez Kelm, Florence; Croce, Carlo; Matar, Chantal; Herceg, Zdenko; Hernandez-Vargas, Hector // BMC Genomics;2013, Vol. 14 Issue 1, p1 

    Background: A subset of breast cancer cells displays increased ability to self-renew and reproduce breast cancer heterogeneity. The characterization of these so-called putative breast tumor-initiating cells (BT-ICs) may open the road for novel therapeutic strategies. As microRNAs (miRNAs)...

  • Role of Estrogen Receptor Signaling in Breast Cancer Metastasis. Roy, Sudipa Saha; Vadlamudi, Ratna K. // International Journal of Breast Cancer;2012, p1 

    Metastatic breast cancer is a life-threatening stage of cancer and is the leading cause of death in advanced breast cancer patients. Estrogen signaling and the estrogen receptor (ER) are implicated in breast cancer progression, and the majority of the human breast cancers start out as estrogen...

  • Morphological profile and receptor status in breast carcinoma: An institutional study. Rao, Chandrika; Shetty, Jayaprakash; HL, Kishan Prasad // Journal of Cancer Research & Therapeutics;Jan-Mar2013, Vol. 9 Issue 1, p44 

    Context: The data on histological and receptor status in breast cancer in an Indian population is limited as receptor status is not routinely carried out for these patients. In the present study, receptor status was analyzed and it was correlated with morphological prognostic parameters....

  • Tumour biomarker expression relative to age and molecular subtypes of invasive breast cancer. Morrison, D H; Rahardja, D; King, E; Peng, Y; Sarode, V R // British Journal of Cancer;7/10/2012, Vol. 107 Issue 2, p382 

    Background:Quantitative differences in biomarker expression relative to age and molecular subtypes have not been well documented in invasive breast cancer (IBCA).Methods:Oestrogen receptor (ER), progesterone receptor (PR), HER2, ki67, p53 and DNA ploidy was performed by image analysis in 162...

Share

Read the Article

Courtesy of NEW JERSEY STATE LIBRARY

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics